Literature DB >> 17000011

How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance?

Chris P Bailey1, Forrest L Smith, Eamonn Kelly, William L Dewey, Graeme Henderson.   

Abstract

The repeated administration of opiate drugs such as morphine results in the development of tolerance to their analgesic, rewarding (euphoric) and respiratory-depressant effects; thus, to obtain the same level of response with subsequent administrations, a greater dose must be used. Tolerance can limit the clinical efficacy of opiate drugs and enhance the social problems that are inherent in recreational opioid abuse. Surprisingly, the mechanism (or mechanisms) underlying the development of morphine tolerance remains controversial. Here, we propose that protein kinase C could have a crucial role in the desensitization of mu-opioid receptors by morphine and that this cellular process could contribute to the development and maintenance of morphine tolerance in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000011     DOI: 10.1016/j.tips.2006.09.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  42 in total

1.  μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.

Authors:  Jamie McPherson; Guadalupe Rivero; Myma Baptist; Javier Llorente; Suleiman Al-Sabah; Cornelius Krasel; William L Dewey; Chris P Bailey; Elizabeth M Rosethorne; Steven J Charlton; Graeme Henderson; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2010-07-20       Impact factor: 4.436

2.  Involvement of protein kinase C in morphine tolerance at spinal levels of rats.

Authors:  Wu-Yang Jin; Long-Chuan Yu
Journal:  ACS Chem Neurosci       Date:  2009-10-05       Impact factor: 4.418

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.

Authors:  N S Abul-Husn; M Sutak; B Milne; K Jhamandas
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

5.  Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.

Authors:  Bichoy H Gabra; Chris P Bailey; Eamonn Kelly; Forrest L Smith; Graeme Henderson; William L Dewey
Journal:  Brain Res       Date:  2008-04-24       Impact factor: 3.252

Review 6.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

Authors:  M J Christie
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

7.  The subtleties of µ-opioid receptor phosphorylation.

Authors:  Eamonn Kelly
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 8.  Site and mechanism of morphine tolerance in the gastrointestinal tract.

Authors:  H I Akbarali; A Inkisar; W L Dewey
Journal:  Neurogastroenterol Motil       Date:  2014-10       Impact factor: 3.598

9.  The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.

Authors:  L C Hull; J Llorente; B H Gabra; F L Smith; E Kelly; C Bailey; G Henderson; W L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2009-12-14       Impact factor: 4.030

10.  Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.

Authors:  C P Bailey; J Llorente; B H Gabra; F L Smith; W L Dewey; E Kelly; G Henderson
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.